Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Future studies are expected to elucidate the safety and efficacy of 5-amino-1MQ, identifying specific populations that may benefit or experience adverse effects
Some local side effects are possible such as needle bruise and swelling
Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): phase 3 study results [Abstract]
There is no FDA oversight on these products, no third-party verification of what is actually in the vial, and no guarantee that the peptide concentration matches what is listed on the label
Most research-peptide GLP-1 vials are 3 mL or 5 mL physical volume holding 10-30 mg of lyophilized peptide
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
